tiprankstipranks
Trending News
More News >
Optimistic Buy Rating on Context Therapeutics Amid Promising Program Developments and Undervaluation
PremiumRatingsOptimistic Buy Rating on Context Therapeutics Amid Promising Program Developments and Undervaluation
2M ago
Context Therapeutics CMO Claudio Dansky Ullmann to depart
Premium
The Fly
Context Therapeutics CMO Claudio Dansky Ullmann to depart
2M ago
Innovative Bispecific Antibody CT-95 Drives Buy Rating for Context Therapeutics
Premium
Ratings
Innovative Bispecific Antibody CT-95 Drives Buy Rating for Context Therapeutics
2M ago
Context Therapeutics doses first patient in Phase 1 trial of CT-95
PremiumThe FlyContext Therapeutics doses first patient in Phase 1 trial of CT-95
3M ago
Context Therapeutics: 2024 Financial and Strategic Highlights
Premium
Company Announcements
Context Therapeutics: 2024 Financial and Strategic Highlights
3M ago
Buy Rating Affirmed for Context Therapeutics Amid Strategic Advancements and Strong Financial Position
Premium
Ratings
Buy Rating Affirmed for Context Therapeutics Amid Strategic Advancements and Strong Financial Position
3M ago
Context Therapeutics Appoints Andy Pasternak as Chairman
PremiumCompany AnnouncementsContext Therapeutics Appoints Andy Pasternak as Chairman
6M ago
Context Therapeutics appoints PAsternak as Chairman of board of directors
Premium
The Fly
Context Therapeutics appoints PAsternak as Chairman of board of directors
6M ago
Context Therapeutics initiated with an Outperform at JMP Securities
Premium
The Fly
Context Therapeutics initiated with an Outperform at JMP Securities
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100